期刊文献+

重组人干扰素-λ1的纯化与鉴定

Purification and identification of recombinant human interferon-lamda 1
下载PDF
导出
摘要 背景:2003年研究发现一个全新的III型干扰素家族,即IFN-λs,包括λ1,2,3三种亚型。目的:对在毕赤酵母中高效表达重组人干扰素-λ1(rhIFN-λ1)进行产率纯度分析,理化性质、受体表达鉴定以及抗肿瘤活性初步探讨。设计、时间及地点:单一样本观察,于2006-09/2008-07在中国医学科学院基础所生物化学与分子生物学系完成。材料:含rhIFNλ1表达质粒的酵母菌种pAO815-4αF-IFNλ1/GS115,人宫颈癌细胞系Hela细胞和HCT116细胞,为中国医学科学院基础所医学分子生物学国家重点实验室保存。方法:诱导含rhIFN-λ1表达质粒的甲醇营酵母Pichia pastoris进行表达,表达产物经阳离子交换层析及凝胶层析纯化。主要观察指标:通过HPLC,质谱,毛细管电泳等鉴定其纯度及理化性质,反转录-聚合酶链反应及real-time荧光定量聚合酶链反应鉴定其在肿瘤细胞中特异受体的表达,应用四甲基偶氮唑盐比色法初步评价其抗肿瘤活性。结果:毕赤酵母表达的rhIFN-1表达水平约9.23mg/L,纯化后的纯度近90%。rhIFN-λ1等电点为8.01,相对分子质量为20960。在Hela和HCT116中均检测到rhIFN-λ1受体小亚基IL-10R2和特异大亚基IL-28RmRNA的表达,但U937细胞中未检测到IL-28RmRNA的表达。rhIFN-λ1具有与IFN-α2a相似的降低细胞增殖的作用,但在经检测无或极少表达IL-28R的细胞中此作用不明显。结论:rhIFN-λ1可以在毕赤酵母中实现高效表达,表达产物的理化性质与天然IFN-λ1一致,具有与IFN-α2a相似的抗肿瘤活性,但对其特异受体分布少的骨髓造血系统降低增殖作用相对较弱。 OBJECTIVE: To analyze the recombinant human interferon- λ 1 (rhIFN-λ1) expressed in Pichia pastoris, further more, to identify its physical and chemical characteristics, expression of receptors, and anti-tumor activities. DESIGN, TIME AND SETTING: The single sample observation was performed at the Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences from September 2006 to July 2008. MATERIALS: The barms pAO815-4α F-IFNλ1/GS115 contained rhIFN λ 1 expressive plasmids, human cervical carcinoma cell Hela and HCT116 cells were preserved in the state key lab for Molecular Biology from Institute of Basic Medical Sciences Chinese Academy of Medical Sciences METHODS: The Pichia pastoris contained rhIFN- λ 1 expressive plasmids was cultured and induced to express IFN-λ 1. The positive ion exchange chromatography and gel chromatography were used to purify the expression product. MAIN OUTCOME MEASURES: The physico-chemical characters of the purified product were tested. The product's IL-10R2 and IL-28R were investigated by RT-PCR and real-time quantitative PCR and its antitumor activity was tested by MTT analysis. RESULTS: The expressed product rhIFN-λ1 yield reached to 9.23 mg/L, and its purity was near 90%. The isoelectric point of rhlFN- 1 was 8.01, with molecular weight of 20 960. The expressions of IL-10R2 and IL-28R were detected in U937 cell. rhlFN-λ1 could decrease the cell proliferation just like IFN-α 2a, but this function was unclearly in the IL-28R cell. CONCLUSION: rhIFN- λ1 can be highly expressed in Pichia pastoris, and its product has the physical and chemical characteristics consistent with natural IFN-λ1, and the anti-tumor activity is similar to IFN-α 2a, however, it is weak in decreasing the proliferation of relatively lowerintensity of receptor distribution in marrow-hematopoiesis system.
作者 赵俊英
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第50期9929-9933,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献21

  • 1LaFleur D, Nardelli B, Tsareva T, et al. Interferon-kappa, a novel type Ⅰ interferon expressed in human keratinocytes. J Biol Chem 2001; 276(43):39765-39771
  • 2Roberts RM, Cross JC, Leaman DW. Interferons as hormones of pregnancv. Endocrinol Rev 1992:13(3):432-452
  • 3Sheppard E Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class Ⅱ cytokine receptor IL-28R. Nat Immunol 2003, 4(1): 63-68
  • 4Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex. Nat Immunol 2003;4(1):69-77
  • 5Stephan B, Florian B, et al.IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005, 289:G960 - G968
  • 6Zitzmann K,Brand S,Baehs S,et al.Novel interferon-λs induce antiproliferative effects in neuroendocrine tumor cells. Biochem Biophys Res Commun 2006;344(4):1334-1341
  • 7Xie Y, Chen H, Huang B. Expression, purification and characterization of human IFN-λ1 in Pichia pastoris. J Biotechnol 2007; 129(3):472-480
  • 8Ank N, West H, Paludan S.IFN-λ:Novel Aniviral Cytokines. J Interferon Cytokine Res 2006;26(6):373-379
  • 9Uze G, Monneron D. IL-28 and IL-29: Newcomers of the interferon family. Biochimie 20071 89729-734
  • 10Dumoutier L, Renauld JC. Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur Cytokine Netw 2002; 13(1):5-15

二级参考文献35

  • 1喻春钊,吴丰华,余源,肖薇,李小兰,陶德定,吴剑宏,龚建平.Camptothecin(CPT)和Cytosine arabinoside(Ara-C)联合应用对MOLT-4细胞株周期特异性凋亡的影响[J].肿瘤,2004,24(4):349-353. 被引量:3
  • 2李明才,何韶衡.人白细胞介素(IL)-28和IL-29基因的克隆与序列分析[J].细胞与分子免疫学杂志,2004,20(5):635-635. 被引量:2
  • 3李岩,黄勇,陈南春,陈苏民.重组人血小板因子4的表达、纯化及活性鉴定[J].第四军医大学学报,2005,26(10):888-891. 被引量:2
  • 4Blankenstein T,Oin Z.The role of IFN—gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis.Curr Opin Immunol,2003.15:148—154.
  • 5Van Deusen J B,Caligiuri Ma.New developments in anti-tumor efficacy and malignant transformation of human natural killer cells、Curr Opin Hematol.2003.10:55—59.
  • 6Chawla—Sarkar M,Lindner D J,Liu Y F.et a1.Apoptosis and interferons:role of interferon—stimulated genes as mediators of apoptosis.Apoptosis,2003,8:237—249.
  • 7Sheppard P,Kindsvogel W,Xu W,et al.IL-28,IL-29 and their class Ⅱ cytokine receptor IL-28R[J].Nat Immunol,2003,4(1):63-68.
  • 8Kotenko SV,Gallagher G,Baurin VV,et al.IFN-λs mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex[J].Nat Immunol,2003,4(1):69-77.
  • 9Coccia EM,Severa M,Giacomini E,et al.Viral infection and Toll-like receptor agonists induce a differential expression of type Ⅰ and λ interferon as in human plasmacytoid and monocyte-derived dendritic cells[J].Eur J Immunol,2004,34(3):796-805.
  • 10Gautier G,Humbert M,Deauvieau F,et al.A type Ⅰ interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells[J].J Exp Med,2005,201(9):1435-1446.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部